237 related articles for article (PubMed ID: 23159945)
1. Synergistic silencing by promoter methylation and reduced AP-2α transactivation of the proapoptotic HRK gene confers apoptosis resistance and enhanced tumor growth.
Xu M; Chen X; Chen N; Nie L; Li X; Li Q; Zeng H; Zhou Q
Am J Pathol; 2013 Jan; 182(1):84-95. PubMed ID: 23159945
[TBL] [Abstract][Full Text] [Related]
2. AP-2 regulates the transcription of estrogen receptor (ER)-beta by acting through a methylation hotspot of the 0N promoter in prostate cancer cells.
Zhang X; Leung YK; Ho SM
Oncogene; 2007 Nov; 26(52):7346-54. PubMed ID: 17525739
[TBL] [Abstract][Full Text] [Related]
3. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
4. Activator protein 2alpha status determines the chemosensitivity of cancer cells: implications in cancer chemotherapy.
Wajapeyee N; Raut CG; Somasundaram K
Cancer Res; 2005 Oct; 65(19):8628-34. PubMed ID: 16204029
[TBL] [Abstract][Full Text] [Related]
5. Identification of HRK as a target of epigenetic inactivation in colorectal and gastric cancer.
Obata T; Toyota M; Satoh A; Sasaki Y; Ogi K; Akino K; Suzuki H; Murai M; Kikuchi T; Mita H; Itoh F; Issa JP; Tokino T; Imai K
Clin Cancer Res; 2003 Dec; 9(17):6410-8. PubMed ID: 14695142
[TBL] [Abstract][Full Text] [Related]
6. The role of HRK gene in human cancer.
Nakamura M; Shimada K; Konishi N
Oncogene; 2008 Dec; 27 Suppl 1():S105-13. PubMed ID: 19641496
[TBL] [Abstract][Full Text] [Related]
7. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.
Zou B; Chim CS; Zeng H; Leung SY; Yang Y; Tu SP; Lin MC; Wang J; He H; Jiang SH; Sun YW; Yu LF; Yuen ST; Kung HF; Wong BC
Gastroenterology; 2006 Dec; 131(6):1835-43. PubMed ID: 17087954
[TBL] [Abstract][Full Text] [Related]
8. Transcription factor specificity protein 1 (SP1) and activating protein 2alpha (AP-2alpha) regulate expression of human KCTD10 gene by binding to proximal region of promoter.
Liu R; Zhou A; Ren D; He A; Hu X; Zhang W; Yang L; Liu M; Li H; Zhou J; Xiang S; Zhang J
FEBS J; 2009 Feb; 276(4):1114-24. PubMed ID: 19154347
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma.
Spugnardi M; Tommasi S; Dammann R; Pfeifer GP; Hoon DS
Cancer Res; 2003 Apr; 63(7):1639-43. PubMed ID: 12670917
[TBL] [Abstract][Full Text] [Related]
10. AP-2alpha and AP-2gamma regulate tumor progression via specific genetic programs.
Orso F; Penna E; Cimino D; Astanina E; Maione F; Valdembri D; Giraudo E; Serini G; Sismondi P; De Bortoli M; Taverna D
FASEB J; 2008 Aug; 22(8):2702-14. PubMed ID: 18443366
[TBL] [Abstract][Full Text] [Related]
11. Defective expression of HRK is associated with promoter methylation in primary central nervous system lymphomas.
Nakamura M; Ishida E; Shimada K; Nakase H; Sakaki T; Konishi N
Oncology; 2006; 70(3):212-21. PubMed ID: 16809940
[TBL] [Abstract][Full Text] [Related]
12. HRK inactivation associated with promoter methylation and LOH in prostate cancer.
Higuchi T; Nakamura M; Shimada K; Ishida E; Hirao K; Konishi N
Prostate; 2008 Jan; 68(1):105-13. PubMed ID: 18008329
[TBL] [Abstract][Full Text] [Related]
13. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
[TBL] [Abstract][Full Text] [Related]
14. TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers.
Conway KE; McConnell BB; Bowring CE; Donald CD; Warren ST; Vertino PM
Cancer Res; 2000 Nov; 60(22):6236-42. PubMed ID: 11103776
[TBL] [Abstract][Full Text] [Related]
15. Silencing of caspase-8 in murine hepatocellular carcinomas is mediated via methylation of an essential promoter element.
Liedtke C; Zschemisch NH; Cohrs A; Roskams T; Borlak J; Manns MP; Trautwein C
Gastroenterology; 2005 Nov; 129(5):1602-15. PubMed ID: 16285959
[TBL] [Abstract][Full Text] [Related]
16. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide.
Lin X; Asgari K; Putzi MJ; Gage WR; Yu X; Cornblatt BS; Kumar A; Piantadosi S; DeWeese TL; De Marzo AM; Nelson WG
Cancer Res; 2001 Dec; 61(24):8611-6. PubMed ID: 11751372
[TBL] [Abstract][Full Text] [Related]
17. Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer.
Sasaki M; Kaneuchi M; Sakuragi N; Dahiya R
Cancer Res; 2003 Jun; 63(12):3101-6. PubMed ID: 12810635
[TBL] [Abstract][Full Text] [Related]
18. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.
Huang EY; Madireddi MT; Gopalkrishnan RV; Leszczyniecka M; Su Z; Lebedeva IV; Kang D; Jiang H; Lin JJ; Alexandre D; Chen Y; Vozhilla N; Mei MX; Christiansen KA; Sivo F; Goldstein NI; Mhashilkar AB; Chada S; Huberman E; Pestka S; Fisher PB
Oncogene; 2001 Oct; 20(48):7051-63. PubMed ID: 11704829
[TBL] [Abstract][Full Text] [Related]
19. Hypermethylation in human cancers of the RIZ1 tumor suppressor gene, a member of a histone/protein methyltransferase superfamily.
Du Y; Carling T; Fang W; Piao Z; Sheu JC; Huang S
Cancer Res; 2001 Nov; 61(22):8094-9. PubMed ID: 11719434
[TBL] [Abstract][Full Text] [Related]
20. Hypermethylation of a small CpGuanine-rich region correlates with loss of activator protein-2alpha expression during progression of breast cancer.
Douglas DB; Akiyama Y; Carraway H; Belinsky SA; Esteller M; Gabrielson E; Weitzman S; Williams T; Herman JG; Baylin SB
Cancer Res; 2004 Mar; 64(5):1611-20. PubMed ID: 14996719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
